Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,152,131
New position
Shares Held
6,076
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#634
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ameritas Advisory Services, LLC holds $48,964,363 across 14 Drug Manufacturers - General names. AZN ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,778 | $16,525,747 | |
| 2 | ABBV |
AbbVie Inc.
|
32,773 | $8,246,997 | |
| 3 | JNJ |
Johnson & Johnson
|
25,667 | $6,518,647 | |
| 4 | AMGN |
Amgen Inc
|
14,119 | $5,112,772 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,071 | $3,735,623 | |
| 6 | NVO |
Novo Nordisk A S
|
48,394 | $2,320,008 | |
| 7 | PFE |
Pfizer Inc
|
88,492 | $2,130,887 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
6,076 | $1,152,131 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,152,131 | 6,076 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||